at the expense of a vast number of unnecessary Caesarean sections. Also since the absolute risks of rupture and other severe complications of VBAC are low, large trials are needed in order to detect differences in the incidence of these complications. The results of the Australian Collaborative Trial of Birth After Caesarean (ACTOBAC) are awaited but it must be noted that this trial was conducted in the face of concerns by consumer groups about the ethics of randomly assigning healthy women with uncomplicated pregnancies to major surgery (for example, see http://www.canaustralia.net/advocacy.htm).In the absence of evidence from random-allocation trials we must base our practice, and the information we provide to women, on what we know from non-randomized cohort studies. A trial of vaginal delivery will be successful in three of every four women and should be encouraged, but it also carries a risk -scar rupture -that women should know about. Also, women opting for VBAC should have the confidence that their obstetric unit has measures in place to minimise the chance of this risk materialising.Unfortunately, it appears that while most units have protocols or guidelines for CS, few have one for VBAC. Studies 9,10 have shown that women often differ from doctors in their choice, and the reasons behind it, of method of delivery after CS, and it has been emphasized that '[p]atient preference cannot be ignored in the delivery equation'. 11 Nevertheless discussion of VBAC, and documentation of same, at the booking appointment and during pregnancy often appears perfunctory.VBAC is an intervention for which specific and valid consent has to be obtained. This means that the woman should be informed of the benefits and success rate but also of the risk. The alternative, an elective CS, should be discussed. In communicating risk, cognizance should be taken of the woman's reproductive history; generally, the success rate of VBAC is higher and risk of scar rupture lower if the woman has had a previous vaginal delivery.Service users also want to be informed of warning signs in labour during VBAC, the philosophy and policies of hospital and staff, and strategies to improve chances of success. 12
AbstractWith rising Caesarean section (CS) rates, more women are having to consider the choice between an elective CS and a vaginal delivery (VBAC) in their subsequent pregnancy. This paper argues that there is an unmet need for clinicians to provide sufficient information to women in this position, so that the woman's choice can be an informed one. Consent should be evidence-based, but there are currently no published random-allocation studies comparing VBAC with elective repeat CS. However the available evidence could be better used by clinicians to facilitate informed choice.